Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid

Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry

(2012) Konstantinos N. Fountoulakis et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Mood-stabilizing drugs: mechanisms of action

(2012) Robert J. Schloesser et al.   TRENDS IN NEUROSCIENCES

Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study

(2011) Ronald Marcus et al.   BIPOLAR DISORDERS

Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress

(2011) Fabio Fumagalli et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials

(2011) Eduard Vieta et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

New treatment guidelines for acute bipolar mania: A critical review

(2011) Alessandra M.A. Nivoli et al.   JOURNAL OF AFFECTIVE DISORDERS

Identification of cis-Elements and Transcription Factors Regulating Neuronal Activity-Dependent Transcription of Human BDNF Gene

(2011) P. Pruunsild et al.   JOURNAL OF NEUROSCIENCE

Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress

(2011) Sung Woo Park et al.   NEUROSCIENCE RESEARCH

Spatial segregation of BDNF transcripts enables BDNF to differentially shape distinct dendritic compartments

(2011) G. Baj et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone

(2011) Philip D. Harvey et al.   SCHIZOPHRENIA RESEARCH

Linking Molecules to Mood: New Insight Into the Biology of Depression

(2010) Vaishnav Krishnan et al.   AMERICAN JOURNAL OF PSYCHIATRY

From trans-methylation to cytosine methylation: Evolution of the methylation hypothesis of schizophrenia

(2010) Dennis R. Grayson et al.   Epigenetics

Long-Term Duloxetine Treatment Normalizes Altered Brain-Derived Neurotrophic Factor Expression in Serotonin Transporter Knockout Rats through the Modulation of Specific Neurotrophin Isoforms

(2010) F. Calabrese et al.   MOLECULAR PHARMACOLOGY

Translational research in bipolar disorder: emerging insights from genetically based models

(2010) G Chen et al.   MOLECULAR PSYCHIATRY

Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?

(2010) Michael S. Fanselow et al.   NEURON

The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action

(2010) Erik H.F. Wong et al.   PHARMACOLOGY & THERAPEUTICS

Distinct 3'UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF)

(2010) A. G. Lau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The acute and chronic effects of combined antipsychotic–mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes

(2010) Carmine Tomasetti et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine

(2010) Francesca Calabrese et al.   PSYCHOPHARMACOLOGY

Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration

(2010) Raffaella Molteni et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Epigenetic mechanisms in schizophrenia

(2009) Tania L. Roth et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Lasting Epigenetic Influence of Early-Life Adversity on the BDNF Gene

(2009) Tania L. Roth et al.   BIOLOGICAL PSYCHIATRY

Cognitive Effects of Second-Generation Antipsychotics

(2009) Fabio Fumagalli et al.   CNS DRUGS

Lurasidone: a new drug in development for schizophrenia

(2009) Jonathan M Meyer et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Lurasidone in the Treatment of Acute Schizophrenia

(2009) Mitsutaka Nakamura et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antipsychotic drug actions on gene modulation and signaling mechanisms

(2009) Raffaella Molteni et al.   PHARMACOLOGY & THERAPEUTICS

Neuronal plasticity: A link between stress and mood disorders

(2009) Francesca Calabrese et al.   PSYCHONEUROENDOCRINOLOGY

The Arc of synaptic memory

(2009) Clive R. Bramham et al.   EXPERIMENTAL BRAIN RESEARCH

Distinct Role of Long 3′ UTR BDNF mRNA in Spine Morphology and Synaptic Plasticity in Hippocampal Neurons

(2008) Juan Ji An et al.   CELL

Dynamic Regulation of Glutamatergic Postsynaptic Activity in Rat Prefrontal Cortex by Repeated Administration of Antipsychotic Drugs

(2008) F. Fumagalli et al.   MOLECULAR PHARMACOLOGY

Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection

(2008) J. A. Lieberman et al.   PHARMACOLOGICAL REVIEWS

Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats

(2007) T ENOMOTO et al.   BEHAVIOURAL BRAIN RESEARCH